Originally described as a novel cell surface biomarker for neural and hematopoietic stem and progenitor cells (HSPCs) [58, 59], prominin-1 has attracted attention in oncology as it highlights cancer cells with stem cell properties [60–63]. Here, PROM1 is linked to cancer.